The Food and Drug Administration rejected two proposed cancer drugs that were developed in China, underscoring a tougher U.S. regulatory stance toward such drugs
The Food and Drug Administration rejected two proposed new cancer drugs that were developed in China, underscoringHong Kong-based Hutchmed Ltd.
said Monday the FDA issued a letter to the company declining to approve its application to market a new drug, surufatinib, for the treatment of pancreatic and neuroendocrine tumors in the U.S. The drug is approved for use in China.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
China Insight: How Can Fashion Enterprises in China Consolidate Their Moat Three Years Into Pandemic?As Shanghai and other Chinese cities continue their weeks-long lockdowns, fashion and beauty brands are having to adapt the way they do business.
Consulte Mais informação »
China Seeks to ‘Normalize’ Mandatory Weekly Coronavirus Tests Regardless of SymptomsAs fresh rounds of mass testing raised apprehension about a possible citywide lockdown in Beijing, Chinese state media on Sunday sought to “normalize” mass nucleic acid testing as a permanent feature of life.
Consulte Mais informação »
China is Building an Asteroid Deflection Mission of its own, due for Launch in 2025There’s an old joke that the dinosaurs are only extinct because they didn’t develop a space agency. The implication, of course, is that unlike our reptilian ancestors, we humans might be able to save ourselves from an impending asteroid strike on Earth, given our six-and-a-half decades of spaceflight experience. But the fact is that while … Continue reading 'China is Building an Asteroid Deflection Mission of its own, due for Launch in 2025'
Consulte Mais informação »
The Navy Extracted a Jet Fighter from 12,400 Feet below the South China SeaBut the U.S. must probe even further to catch up with China’s access to the ocean’s deepest reaches
Consulte Mais informação »
China Social Media Bilibili Trims Revenue Forecast, Gets A Bump In Users Amid Lockdowns'The near-term financial impact of Covid-19 is rapidly evolving and difficult to predict'
Consulte Mais informação »
China silences prominent market analyst as economic slump deepensChinese social media have shut down the accounts of a prominent market analyst who drew attention in recent weeks to the dramatic slowdown in the country's economy and the effects of government policy on the tech industry.
Consulte Mais informação »